Trending Now
Top Managers See 2022 as Banner Year for Oil Stocks (PXD,...
As we kick off 2022, it’s worth noting that Blackrock’s legendary investment manager, Byron Wien, once again put out his Top Ten...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Editas Medicine Inc (NASDAQ:EDIT) Strikes Multi-Year Deal With Azzur Group For...
Editas Medicine Inc (NASDAQ:EDIT) recently announced that it signed a multi-year deal with Azzur Group, facilitating the production of pipeline treatments at current Good...
MAKE IT MODERN
LATEST REVIEWS
Vallon Pharmaceuticals Inc (VLON) stock could be just getting started
Vallon Pharmaceuticals, Inc. (VLON) closed on Friday at $0.4625 with a gain of $0.1945 or +72.57%. VLON didn't stop there and went...
MAKE IT MODERN
PERFORMANCE TRAINING
Rexahn Pharmaceuticals Inc. (NASDAQ:REXN) Enters Definitive Merger Agreement With Ocuphire Pharma
Rexahn Pharmaceuticals Inc. (NASDAQ:REXN) has announced that it has entered a definitive merger agreement with privately-held ophthalmic biopharmaceutical firm, Ocuphire Pharma Inc.
Rexahn to merge...
Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) Report Encouraging FDA Meeting Results For MAT9001 in SHTG
Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) has announced the End of Phase two meeting with the FDA regarding the registration pathway and development for MAT9001,...
Paypal Holdings Inc (NASDAQ:PYPL) short term trade alert
I really like the look of PayPal (NASDAQ:PYPL) here on the short-term charts. The stock made a strong move since October and...
MacroGenics Inc. (NASDAQ:MGNX) Reports Its Q3 Financial Results and Clinical Updates Of Flotetuzumab and...
MacroGenics Inc. (NASDAQ:MGNX) has reported its Q3 2020 financial results and provided its corporate progress update.
MacroGenics advancing three programs
Scott Koenig, the company's CEO...
Theravance Biopharma Inc. (NASDAQ: TBPH) enrolls the first patient in the study evaluating YUPELRI...
Theravance Biopharma Inc. (NASDAQ: TBPH) has announced the recruitment of the first patient in a fourth phase YUPELRI (revefenacin) inhalation solution.
YUPELRI has potential as...
MAKE IT MODERN
